Everest Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221K Buy
+3,549
New +$224K 0.07% 105
2026
Q2
– Sell
-3,469
Closed -$210K – 87
2026
Q1
$210K Buy
+3,469
New +$202K 0.11% 70

Other funds holding BMY

Everest Management's BMY Position: Q3 2026 in Review

Everest Management opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 3,549 shares worth $221K. The stake represents 0.07% of the portfolio and ranks #105 among its holdings. This is a return to the name: Everest Management previously reported a position in BMY as recently as Q1 2026.

Everest Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Everest Management held 3,549 shares of Bristol-Myers Squibb worth $221K as of Q3 2026.
  • Bristol-Myers Squibb was a new Everest Management position in Q3 2026.
  • Bristol-Myers Squibb made up 0.07% of Everest Management's portfolio in Q3 2026, its #105 holding.
  • Everest Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Everest Management's 13F filing for Q3 2026, filed 10 Nov 2026.